Pure Global AI
NCT05582681Recruiting

HCV Test and Treat Utilizing Simplified HCV Patient Education

Weill Medical College of Cornell UniversityPhase 4ClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Hepatitis C
Drug/Device/Intervention
Cepheid POC HCV Viremia (RNA) test
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Weill Medical College of Cornell University
Location
Long Island City,New York,New York, United States of America
Timeline & enrollment
Phase
Phase 4
Start date
Nov 11, 2022
End date
Oct 01, 2027
Enrollment
200 participants
Primary outcome

Number of subjects who initiated treatment within 8-week window from enrollment.

Summary

The study hypothesis is that the test and treat model utilizing video-based patient education
 will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment
 completion.

ICD-10 classifications
Acute hepatitis CChronic viral hepatitis CViral hepatitisChronic viral hepatitisUnspecified viral hepatitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05582681
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05582681 through Pure Global AI's free database. This Phase 4 trial is sponsored by Weill Medical College of Cornell University and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.